Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-000794
Filing Date
2021-01-19
Accepted
2021-01-19 06:03:56
Documents
2
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1400
2 bcda20210115b_sec16.htm EX-24 8210
  Complete submission text file 0001437749-21-000794.txt   11300
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Issuer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELLADON CORPORATION 12760 HIGH BLUFF DRIVE, SUITE 240 SAN DIEGO CA 92130
Business Address
ZSEBO KRISZTINA M (Reporting) CIK: 0001590703 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38999 | Film No.: 21533706